Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
about
Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Anamorelin (ONO-7643) for the ...... panese patients (ONO-7643-04).
@en
Anamorelin (ONO-7643) for the ...... panese patients (ONO-7643-04).
@nl
type
label
Anamorelin (ONO-7643) for the ...... panese patients (ONO-7643-04).
@en
Anamorelin (ONO-7643) for the ...... panese patients (ONO-7643-04).
@nl
prefLabel
Anamorelin (ONO-7643) for the ...... panese patients (ONO-7643-04).
@en
Anamorelin (ONO-7643) for the ...... panese patients (ONO-7643-04).
@nl
P2093
P2860
P50
P356
P1433
P1476
Anamorelin (ONO-7643) for the ...... panese patients (ONO-7643-04).
@en
P2093
Hiromoto Kitajima
Hiroshi Saito
Kazuhiro Sato
Keisuke Aoe
Kenji Eguchi
Koichi Takayama
Kouzo Yamada
Kozo Yoshimori
Masashi Kondo
Naoyuki Komura
P2860
P304
P356
10.1002/CNCR.31128
P407
P577
2017-12-04T00:00:00Z